ETFs Holding NEOS »    NEOS Historical Stock Prices »
NEOS News Video: Tue, Oct 20, 2015, 1:08 PM — Tuesday Sector Laggards: Drugs, Biotechnology Stocks

If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Neos Therapeutics is a pharmaceutical company that develops, manufactures and commercializes products utilizing its modified-release drug delivery technology platform, which it has already used to develop Adzenys extended-release (XR)-orally disintegrating tablets (ODT), Cotempla XR-ODT and Adzenys ER oral suspension, which are its marketed products, for the treatment of attention deficit hyperactivity disorder (ADHD). Co.'s products incorporate two prescribed medications for the treatment of ADHD, methylphenidate and amphetamine. Co.'s marketed products also include Generic Tussionex, which consists of hydrocodone and chlorpheniramine for cough and upper respiratory symptoms of a cold. Self directed investors in Neos Therapeutics Inc will be interested in keeping up with all Neos Therapeutics Inc news they can find, both NEOS news originating from the company in the form of press releases, as well as seeing how independent media outlets are reporting news on NEOS. At RediNews, we simplify this task by presenting both NEOS news releases originating from Neos Therapeutics Inc itself, and NEOS news from a variety of media outlets. Visitors can browse this news online and through our NEOS RSS news feed.


NEOS News — Articles, Videos, & Press Releases

VTI's Underlying Holdings Could Mean 10% Gain Potential
Monday, May 13, 2019, 8:14 AM — ETF Channel
Analysts Predict 26% Upside For The Holdings of IWC
Friday, April 12, 2019, 8:05 AM — ETF Channel
Surprising Analyst 12-Month Target For SPTM
Tuesday, March 12, 2019, 8:04 AM — ETF Channel
IWV's Holdings Imply 12% Gain Potential
Thursday, February 7, 2019, 8:01 AM — ETF Channel
NEOS: Insiders vs. Shorts
Tuesday, January 29, 2019, 2:20 PM — Market News Video
Implied SPSM Analyst Target Price: $36
Monday, January 7, 2019, 7:44 AM — ETF Channel
Analysts See 23% Gains Ahead For SPSM
Wednesday, November 14, 2018, 8:24 AM — ETF Channel
Adding Up The Components: Russell 2000 Could Rise 21%
Thursday, October 11, 2018, 8:09 AM — ETF Channel
Neos Therapeutics Enters Oversold Territory (NEOS)
Wednesday, September 26, 2018, 11:55 AM — Dividend Channel
Commit To Purchase Neos Therapeutics At $2.50, Earn 6.2% Annualized Using Options
Monday, September 24, 2018, 11:49 AM — Stock Options Channel
Peek Under The Hood: IWO Has 12% Upside
Friday, September 7, 2018, 8:00 AM — ETF Channel
The Math Shows EQWS Can Go To $54
Tuesday, August 7, 2018, 8:52 AM — ETF Channel
Relative Strength Alert For Neos Therapeutics
Monday, July 30, 2018, 12:02 PM — Dividend Channel
Notable Thursday Option Activity: CMPR, TWTR, NEOS
Thursday, July 26, 2018, 3:24 PM — Stock Options Channel
Short Interest In Neos Therapeutics Makes 14% Move
Thursday, July 12, 2018, 11:47 AM — Market News Video
Neos Therapeutics Enters Oversold Territory (NEOS)
Tuesday, June 26, 2018, 11:56 AM — Dividend Channel
Commit To Buy Neos Therapeutics At $5, Earn 15.3% Annualized Using Options
Thursday, June 21, 2018, 12:03 PM — Stock Options Channel
Analysts See 10% Upside For The Holdings of SPSM
Friday, June 1, 2018, 7:36 AM — ETF Channel
NEOS is categorized under the Healthcare sector; below are links to news for some other companies in the same sector:

GBT News
EDG News

Consider RediNews RSS feeds to complement your web page financial content. Whether below a detailed quote page, a stock history chart, or featured on your home page, RediNews has an RSS feed to meet your needs. Integrate news by specific stock symbol, or an entire market sector. Simply navigate to any RediNews news page by specific ticker symbol, then click the RSS icon for any news page to reach the associated RSS feed (the icon will look like this): .

NEOS News | | Copyright © 2013 - 2019, All Rights Reserved

Nothing in is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.